
A pharmaceutical company group with traditional Chinese medicine as its main focus which is among the Fortune Global 500.
Establishment of consolidated reporting system platform and data analysis, financial management information platform.
Establishment of consolidated reporting system platform and data analysis, financial management information platform.
Accounting system financial management information platformization. Automatic data interfacing of multiple accounting systems to improve schedule automation.
Standardised budget process. Accurate output of consolidated statements and reduced time to produce consolidated statements.
An integrated financial analysis platform. Master data management and business management standardisation. Rapid completion of business financial statements.
Unified management of global base parameters, process-oriented and unified management of Solvency II management and analysis operations.
By allocating expenses through the system, the data can be easily queried and the logic can be conveniently modified to improve efficiency.